Enfusion, Inc. (ENFN) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -57.14%. A quarter ago, it was expected that this company would post earnings of $0.06 per share when it actually produced earnings of $0.05, delivering a surprise of -16.67%.Over the last four quarters, the company ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission file number: 001-40949 ENFUSION, INC. (Exact name of registrant as specified in its charter) Delaware 87-1268462 (State of Other Jurisdiction ...

Exhibit 2.1 EXECUTION COPY AGREEMENT AND PLAN OF MERGER by and among ENFUSION, INC., ENFUSION LTD. LLC, CLEARWATER ANALYTICS HOLDINGS, INC. POSEIDON ACQUIRER, INC. POSEIDON MERGER SUB I, INC. and POSEIDON MERGER SUB II, LLC JANUARY 10, 2025 TABLE OF CONTENTS | | Page | | --- | --- | | ARTICLE I DEFINITIONS | 2 | | Section 1.01 Definitions | 2 | | Section 1.02 Other Defined Terms | 20 | | Section 1.03 Other Definitional and Interpretative Provisions | 24 | | ARTICLE II THE MERGERS | 25 | | Section 2.01 The C ...

Piper Sandler analyst Arvind Ramnani upgraded the shares of Clearwater Analytics Holdings Inc CWAN from Neutral to Overweight and raised the price forecast from $28.00 to $36.00.CWAN delivered strong fourth-quarter results, with revenue of $126.5 million, exceeding the Street’s forecast of $120.3 million, reflecting a 27.7% year-over-year increase compared to the Street’s expectation of 21.5% growth.The analyst noted that CWAN’s fourth-quarter performance surpassed expectations in both revenue and margins. ...

Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm ...

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud ...

Enfusion, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm ...

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Enfusion Inc For Securities Fraud ...

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:Enfusion, Inc. (NYSE: ENFN)'s sale to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock. If you are an Enfusion shareholder, click here to learn more about your rights and options.Intra-Cellular Therapies, Inc. ...

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation ...